• Tidak ada hasil yang ditemukan

sear vpdupdate week16 2018

N/A
N/A
Protected

Academic year: 2018

Membagikan "sear vpdupdate week16 2018"

Copied!
14
0
0

Teks penuh

(1)

Immunization and Vaccine

Development (IVD) SEARO

Protecting People from Vaccine

Preventable Diseases

(2)

Last wild poliovirus cases confirmed by type, SEAR

*Dots are randomly placed within blocks (Sub-districts)

Data as of 23 April 2018

WPV Type 2

District: Aligarh

State: Uttar Pradesh (India)

Date of onset: 24-Oct-1999

WPV Type 3

District: Pakur

State: Jharkhand (India)

Date of onset: 22-Oct-2010

WPV Type 1

District: Howrah

State: West Bengal (India)

Date of onset: 13-Jan-2011

Country

Year

Bangladesh

2006

Bhutan

1986

DPR Korea

1996

India

2011

Indonesia

2006

Maldives

1994

Myanmar

2007

Nepal

2010

Sri Lanka

1993

Thailand

1997

Timor-Leste

1995

(3)

Monthly Distribution of AFP Cases

SEAR, 2017

2018

Data as of 23 April 2018

Bangladesh

1 363

363

135

147

126

96

153

109

110

128

80

46

80

100

120

63

23-Apr-18

Bhutan

9

1

1

2

0

0

1

0

3

1

0

1

0

1

0

0

21-Apr-18

DPR Korea

104

0

8

13

7

13

6

11

6

14

1

1

0

0

0

0

05-Feb-18

India

39 339

8 512

2 867

2 744

3 048

3 136

3 961

4 746

3 755

3 175

3 086

2 927

2 908

2 634

2 418

552

20-Apr-18

Indonesia

1 689

292

113

109

118

77

118

145

152

236

282

121

106

97

85

4

16-Apr-18

Maldives

7

3

1

2

0

0

1

0

0

0

1

2

0

0

2

1

23-Apr-18

Myanmar

396

45

14

18

24

28

52

64

39

37

44

34

25

15

5

0

23-Apr-18

Nepal

371

94

34

32

33

24

38

43

21

26

21

37

28

23

32

11

22-Apr-18

Sri Lanka

70

16

6

4

6

4

1

6

3

11

5

4

4

6

3

3

20-Apr-18

Thailand

198

15

16

6

11

15

21

27

16

10

16

11

8

4

3

0

18-Apr-18

Timor-Leste

3

0

0

0

1

0

0

1

0

1

0

0

0

0

0

0

04-Dec-17

TOTAL

43 549

9 341

3 195

3 077

3 374

3 393

4 352

5 152

4 105

3 639

3 536

3 184

3 159

2 880

2 668

634

Ju

l-1

7

M

a

r-1

8

A

p

r-1

8

Date of last

report

S

e

p

-1

7

O

ct

-1

7

N

o

v

-1

7

D

e

c-1

7

Ja

n

-1

8

F

e

b

-1

8

M

a

r-1

7

A

p

r-1

7

M

a

y

-1

7

Ju

n

-1

7

AFP cases by month of paralysis onset, last 14 months (data from weekly case-based reports)

Country

2017

total

AFP

2018

AFP to

date

A

u

g

-1

(4)

Primary Culture Results from AFP Cases, 2017

Data as of 23 April 2018

<14 days >14 days

V

a

c

c

ine

V

D

P

V

W

il

d

Bangladesh

IPH, Dhaka

1 355

17

3

306

1 029

0

0

2 705

90.8

19.0

84

1

0

0

Bhutan

NIH, Bangkok

4

0

0

1

3

0

0

8

100

25

0

0

0

0

DPRK

NPL, Pyongyang

98

0

0

14

84

0

0

200

94.8

14.0

0

0

0

0

BJMC, Ahmedabad

5 448

201

30

1 059

4 158

0

0

10 873

96.1

16.0

10

0

0

0

NIV, Bengaluru

3 509

126

24

951

2 408

0

0

7 017

96.7

22.5

5

0

0

0

IoS, Kolkatta

5 876

163

19

1 312

4 382

0

0

11 749

84.4

17.8

0

0

0

0

KIPM, Chennai

3 644

44

7

672

2 921

0

0

7 255

99.3

15.0

0

0

0

0

NCDC, Delhi

6 053

181

21

834

5 017

0

0

12 082

97.9

11.8

5

0

0

0

CRI, Kasauli

1 984

20

1

298

1 665

0

0

3 975

99.8

11.7

0

0

0

0

SGPGI, Lucknow

8 971

252

34

2 064

6 621

0

0

17 929

92.6

18.0

5

0

0

0

ERC, Mumbai

2 899

142

13

501

2 243

0

0

5 810

93.6

15.1

9

0

0

0

India Sub Total

38 384

1 129

149

7 691

29 415

0

0

76 690

94.1

16.3

34

0

0

0

Bio Farma, Bandung

506

2

0

40

464

0

0

1 002

88

7.5

0

0

0

0

NIHRD, Jakarta

617

3

0

52

558

0

4

1 219

100

7.2

0

0

0

0

PHL, Surabaya

499

1

0

51

447

0

0

984

100

9.0

0

0

0

0

Indonesia Sub Total

1 622

6

0

143

1 469

0

4

3 205

96.2

7.8

0

0

0

0

Maldives

MRI, Colombo

2

0

0

0

2

0

0

3

100

0

0

0

0

0

Myanmar

NHL, Yangon

395

5

1

62

327

0

0

794

93

13.6

0

0

0

0

NIH, Bangkok

369

4

1

85

279

0

0

738

99

20.6

24

0

0

0

Labs in India

3

0

0

0

0

0

0

0

0

0

0.0

0

0

0

0

Sri Lanka

MRI, Colombo

43

0

0

0

43

0

0

93

97

0.0

292

1

0

0

Thailand

NIH, Bangkok

129

4

1

10

107

0

7

258

99.2

7.4

0

0

0

0

Timor-Leste

NIH, Bangkok

0

42 401

1 165

155

8 312

32 758

0

11

84 694

94.1

16.0

434

2

0

0

1

Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.

2

Stool samples collected from contact and healthy children survey.

3

Stool samples from cross notified AFP cases tested in India

Country

Polio Laboratories

Number of AFP

cases with

specimens

received in Lab

AFP cases

AFP specimens

%

N

P

E

V

Specimens from other sources

2

Positive

Culture

Number

received by

lab

Results

Positive

Culture +

NPEV

Received

by lab

% Primary Culture

Reports Within 14

(5)

Primary Culture Results from AFP Cases, 2018

Data as of 23 April 2018

<14 days >14 days

V

a

c

c

ine

V

D

P

V

W

il

d

Bangladesh

IPH, Dhaka

361

3

0

39

198

65

56

722

98.8

12.1

25

0

0

0

Bhutan

NIH, Bangkok

0

DPRK

NPL, Pyongyang

0

BJMC, Ahmedabad

1 290

103

7

120

953

107

0

2 566

98.8

7.9

0

0

0

0

NIV, Bengaluru

741

58

5

98

492

86

2

1 481

95.5

12.7

0

0

0

0

IoS, Kolkatta

997

80

2

116

773

24

2

1 971

93.6

8.6

0

0

0

0

KIPM, Chennai

822

46

2

80

694

0

0

1 611

100.0

7.4

0

0

0

0

NCDC, Delhi

1 336

80

10

76

1 028

142

0

2 669

99.8

5.6

0

0

0

0

CRI, Kasauli

407

14

0

24

350

19

0

811

100.0

4.4

0

0

0

0

SGPGI, Lucknow

1 502

101

8

168

1 105

120

0

3 005

98.7

8.9

0

0

0

0

ERC, Mumbai

793

67

2

58

666

0

0

1 555

98.2

6.1

5

0

0

0

India Sub Total

7 888

549

36

740

6 061

498

4

15 669

98.1

7.8

5

0

0

0

Bio Farma, Bandung

100

0

0

5

87

7

1

200

95

4.9

0

0

0

0

NIHRD, Jakarta

74

2

0

2

57

8

5

145

100

2.5

0

0

0

0

PHL, Surabaya

90

2

0

7

78

2

1

175

100

7.1

0

0

0

0

Indonesia Sub Total

264

4

0

14

222

17

7

520

98.1

5.0

0

0

0

0

Maldives

MRI, Colombo

0

Myanmar

NHL, Yangon

44

0

0

6

38

0

0

88

97

12.5

20

4

0

0

NIH, Bangkok

70

0

0

5

58

7

0

140

99

7.1

26

1

0

0

Labs in India

3

0

Sri Lanka

MRI, Colombo

8

0

0

1

6

1

0

16

100

14.3

50

0

0

0

Thailand

NIH, Bangkok

0

Timor-Leste

NIH, Bangkok

0

8 635

556

36

805

6 583

588

67

17 155

98.1

7.9

126

5

0

0

1

Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.

2

Stool samples collected from contact and healthy children survey.

3

Stool samples from cross notified AFP cases tested in India

Country

Polio Laboratories

Number of AFP

cases with

specimens

received in Lab

AFP cases

AFP specimens

%

N

P

E

V

Specimens from other sources

2

Positive

Culture

Number

received by

lab

Results

Positive

Culture +

NPEV

Received

by lab

% Primary Culture

Reports Within 14

(6)

Poliovirus Detected in Sewage Samples, India, 2017

(7)

Poliovirus Detected in Sewage Samples, India, 2018

(8)

Laboratory Data of Environmental Surveillance 2015-2018,

NPML,IPH Bangladesh, Report: April 23,2018)

Site

City # Site 1 2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Dhaka Niketon 1 3 6 9

Gazipur Esthema 2 4 7 10

Dhaka Gulshan 5 8 11

Dhaka Bashabo

Site

City # Site 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Dhaka Niketon 14 17 20 23 26 29 32 35 38 41 44 47 50 53 59 62 65 68 71 74 77 80 83 85 86 89 Gazipur Esthema 13 16 18 22 25 28 31 34 37 40 43 46 49 52 55 58 61 64 67 70 73 76 79 82 88 91 Dhaka Gulshan 12 15 19 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 84 87 90 Dhaka Bashabo

Report on Epidemiological Week 52, 2017, NPML-IPH, Bangladesh: total collected 102; NPEV 74(72%) ; Polio/vaccine:10(SL1- 3; SL3-7)

Site

City # Site 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Dhaka Niketon 92 95 96 100 104 108 112 116 120 124 128 132 136 140 144 148 152 156 160 164 168 172 176 180 184 188 192 Gazipur Esthema 99 203 107 111 115 119 123 127 131 134 138 142 146 150 154 158 162 166 170 174 178 182 186 190 Dhaka Gulshan s94 98 102 106 110 114 118 122 125 129 133 137 141 145 149 153 157 161 165 169 173 177 181 185 189 193 Dhaka Bashabo s93 97 101 105 109 113 117 121 126 130 135 139 143 147 151 155 159 163 167 171 175 179 183 187 191

Site

Report on Epidemiological Week 17, 2018, NPML-IPH, Bangladesh_sample collected in 2018-40; NPEV-18; SL3-8; Mix(SL3+SL1), SL1-1; Neg-11; Under test process-2

City # Site 1 2 3 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Dhaka Niketon 196 211 215 219 223 227 231

Gazipur Esthema194 198 202 213 217 221 225 229 233

Dhaka Gulshan 197 201 212 216 220 224 228 232

Dhaka Bashabo195 199 210 214 218 222 226 230

Cox'BazarUkhia-K 203 204

Ukhia-B 205 206

Teknaf-L 207 208

Teknaf-Ch

Sites:

Bangladesh, Sample collected fortnightlSummary

: : Total site 4+4

Total sample collected

WPV1

Site 1= Hatirjheel-Niketon,Dhaka

Total sample with result available:

231

VDPV

Site 2= Esthema-Kamarpara,Tongi)

Total sample positive for WPV(with type)

0

SLPV2 SLPV1

Site 3= Wasa Sewarage Pit-Gulshan,Dhaka

Total sample positive for VDPV

0

SL PVV3

Site 4= Bashabo Sewarage pit,Dhaka

Total sample positive for SLPV3

17

NPEV

Total sample positive for SLPV2

1

Negetive (NVE)

New sites: Cox's Bazar, Chittagong

Total sample positive for SLPV1

6

Discordant

Ukhiya-Kutupalong

Total sample positive for NPEV

123

under test process

Ukhiya- Balukhali 1

Total RD Positive:

147

SL1+SL3Mix

Teknaf-Leda

Total sample NVE:

84

Not collected

Teknaf-Chakmarkul

Under test proce1

Reported by Dr. K Mahbuba Jamil, Virologist, National Polio(AFP-ES) Measles-Rubella and AMES(JE) Laboratory, IPH, Bangladesh

Note: NPML-IPH lab processes: Sewage samples are tested in cell culture, virus isolation done, confirmed by realtime PCR (ITD)

Note:

ERC sequencing report has confirmed the ES-158-ITD discordant sample finally as"PV SL3(vaccine) with 2 neucleotide change"

.

Year 2018 Year 2015

Year 2016

Year 2017

233

4

4

200

(9)

Poliovirus Detected in Sewage Samples, Thailand, 2016-2018

Data as of 21 April 2018

*specimens collected since week 48, 2016

Sampling site

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Bangkok

Samut Sakhon

Sampling site

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Bangkok

Samut Sakhon

Sampling site

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Bangkok

Samut Sakhon

Type 1 Sabin

Type 1 VDPV

Wild polio type 1

Negative for Polio and NPEV

Type 2 Sabin

Type 2 VDPV

Wild polio type 3

Result pending

Type 3 Sabin

Type 3 VDPV

NPEV

Sampling not scheduled

Type 1 Sabin + 3 Sabin

2016

2017

Start to use two-phases separation with Dextran and PEG6000 for sewage sample concentration since week18/2017

(10)

Poliovirus Detected in Sewage Samples, Nepal, 2017-2018

Data as of 21 April 2018

*specimens collected since week 50, 2017

Sampling site

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Bagmati-Pachali

Bagmati Manahara Confluence

Bagmati Dhobikhola Confluence

Tukucha

Sewer inlet chamber - Guheshwari

Sobhabhagawati

Sampling site

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Bagmati Manahara Confluence

Bagmati Dhobikhola Confluence

Tukucha

Sewer inlet chamber - Guheshwari

Sobhabhagawati

Type 1 Sabin

Type 1 VDPV

Wild polio type 1

Negative for Polio and NPEV

Type 2 Sabin

Type 2 VDPV

Wild polio type 3

Result pending

Type 3 Sabin

Type 3 VDPV

NPEV

Sampling not scheduled

Type 1 Sabin + 3 Sabin

2018

(11)

Poliovirus Detected in Sewage Samples, Indonesia, 2017-2018

Data as of 16 April 2018

Province

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

DI Yogyakarta

DKI Jakarta

East Java

West Java

Province

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

DI Yogyakarta

DKI Jakarta

East Java

South Kalimantan

South Sulawesi

South Sumatera

West Java

Type 1 Sabin

Type 1 VDPV

Wild polio type 1

Negative for Polio and NPEV

Type 2 Sabin

Type 2 VDPV

Wild polio type 3

Result pending

Type 3 Sabin

Type 3 VDPV

NPEV

Sampling not scheduled

Type 1 Sabin + 3 Sabin

Indonesia - 2017

(12)

Poliovirus Detected in Sewage Samples, Myanmar, 2017-2018

Data as of 12 April 2018

*specimens collected since week 47, 2017

Sampling site

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Yangon

Sitwe

Sampling site

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Yangon

Sitwe

Maung Taw

Type 1 Sabin

Type 1 VDPV

Wild polio type 1

Negative for Polio and NPEV

Type 2 Sabin

Type 2 VDPV

Wild polio type 3

Result pending

Type 3 Sabin

Type 3 VDPV

NPEV

Sampling not scheduled

Type 1 Sabin + 3 Sabin

2017

(13)

Measles and Rubella Serology (IgM), 2017

Source: SEAR Monthly lab reports

Data as of 28 February 2018

# % # %

Banglade s h Dhaka 6497 6497 2696 41.5 228 6.0 69.1

Bhutan Thimphu 441 441 65 14.7 8 2.1 93.0

DPR Kore a Pyongyang 106 106 0 0.0 0 0.0 0.0

Ahmedabad 464 464 327 70.5 30 21.9 100.0 Bengaluru 779 705 165 23.4 174 32.2 92.1 Bhopal 193 193 143 74.1 4 8.0 98.4 Chandigarh 123 123 43 35.0 11 13.8 100.0 Chennai 1029 200 50 25.0 75 50.0 98.5 Delhi 159 159 105 66.0 6 11.1 97.5 Guw ahati 278 158 108 68.4 14 28.0 100.0 Hyderabad 125 125 54 43.2 11 15.5 100.0 Jaipur 343 343 238 69.4 9 8.6 81.9 Kolkata 1070 1070 450 42.1 344 55.5 89.2 Lucknow 2124 1926 1212 62.9 96 13.4 77.8 Patna 488 488 184 37.7 120 39.5 68.9 Pune 699 522 310 59.4 45 21.2 91.4

7874 6476 3389 52.3 939 30.4 86.6

Bandung 1184 1184 585 49.4 182 30.4 93.2 Jakarta 5350 4942 1260 25.5 1548 42.0 20.3 Surabaya 4277 3122 1569 50.3 534 34.4 55.6 Yogyakarta 3990 3990 1024 25.7 1319 44.5 73.1

14801 13238 4438 33.5 3583 40.7 51.1

Maldive s Male 66 66 1 1.5 1 1.5 89.4

Myanm ar Yangon 1631 1630 1041 63.9 8 1.4 98.3

Ne pal Kathmandu 916 916 63 6.9 22 2.6 92.5

Sri Lank a Colombo 241 240 5 2.1 10 4.3 87.5

Bangkok 615 615 316 51.4 3 1.0 100.0 Chiang Mai 170 170 103 60.6 0 0.0 100.0 Chiang Rai 39 39 9 23.1 0 0.0 89.7 Chon Buri 255 174 59 33.9 1 0.9 100.0 Khon Kaen 55 55 11 20.0 1 2.3 100.0 Nakhon Saw an 8 8 3 37.5 0 0.0 100.0 Nakhonratchasima 71 71 28 39.4 4 9.3 97.2 Phitsanulok 58 58 15 25.9 2 4.7 100.0 Samut Songkhram 460 460 276 60.0 5 2.7 98.3 Songkhla 795 795 631 79.4 3 1.8 100.0 Surat Thani 18 18 3 16.7 0 0.0 100.0 Trang 64 64 10 15.6 9 16.7 100.0 Ubon Ratchathani 57 57 10 17.5 1 2.1 100.0 Udon Thani 15 15 5 33.3 0 0.0 100.0

2680 2599 1479 56.9 29 2.6 99.5

Tim or-Le s te Dili 126 126 0 0.0 3 2.4 92.1

35379 32335 13177 40.8 4831 25.2 70.1

Source: Reported by SEAR Measles Laboratory Netw ork NR=No Report

India Total

Country Laboratorie s Num be r of Se rum

Sam ple s Re ce ive d Num be r Te s te d Me as le s +ve Rube lla +ve

India

Re s ults

% Me as le s Re s ults Re porte d w ithin 4 Days

Indone s ia

Indone s ia Total

Thailand

Thailand Total

(14)

Measles and Rubella Serology (IgM), 2018

Source: SEAR Monthly lab reports

# % # %

Banglade s h Dhaka 359 359 151 42.1 14 6.7 99.7

Bhutan Thimphu 31 31 8 25.8 1 4.3 58.1

DPR Kore a Pyongyang NR NR NR NR NR NR NR

Ahmedabad 90 90 44 48.9 10 21.7 98.9 Bengaluru 87 82 18 22.0 0 0.0 95.1 Bhopal 46 46 41 89.1 0 0.0 97.8 Chandigarh 43 41 29 70.7 0 0.0 100.0 Chennai 189 39 2 5.1 15 40.5 92.3 Delhi 62 62 49 79.0 0 0.0 91.9 Guw ahati 15 10 4 40.0 3 50.0 100.0 Hyderabad 34 34 4 11.8 0 0.0 82.4 Jaipur 63 63 50 79.4 0 0.0 98.4 Kolkata 212 212 116 54.7 45 46.9 94.3 Lucknow 675 526 384 73.0 7 4.9 85.0 Mumbai 231 166 116 69.9 10 20.0 63.9 Patna 141 141 113 80.1 19 67.9 27.7

Pune NR NR NR NR NR NR NR

1888 1512 970 64.2 109 20.1 81.9

Bandung 44 44 1 2.3 9 20.9 100.0 Jakarta 258 220 34 15.5 64 34.4 92.3 Surabaya 297 297 208 70.0 61 68.5 94.6 Yogyakarta 214 214 7 3.3 36 17.4 90.2

813 775 250 32.3 170 32.4 93.0

Maldive s Male 5 5 0 0.0 0 0.0 100.0

Myanm ar Yangon 69 69 31 44.9 1 2.6 95.7

Ne pal Kathmandu 197 88 8 9.1 2 2.5 0.0

Sri Lank a Colombo 21 21 1 4.8 0 0.0 85.7

Bangkok 51 51 24 47.1 2 7.4 100.0 Chiang Mai 59 59 45 76.3 0 0.0 100.0

Chiang Rai 0 0 0 NR 0 NR NR

Chon Buri 29 29 7 24.1 0 0.0 100.0 Khon Kaen 12 12 4 33.3 0 0.0 100.0 Nakhon Saw an 0 0 0 NR 0 NR NR Nakhonratchasima 22 22 9 40.9 0 0.0 100.0 Phitsanulok 2 2 0 0.0 0 0.0 100.0 Samut Songkhram 32 32 14 43.8 0 0.0 100.0 Songkhla 10 10 0 0.0 1 10.0 100.0 Surat Thani 1 1 0 0.0 0 0.0 100.0

Trang 7 7 0 0.0 0 0.0 100.0

Ubon Ratchathani 61 61 20 32.8 2 4.9 100.0 Udon Thani 137 137 49 35.8 1 1.1 100.0

423 423 172 40.7 6 2.4 100.0

Tim or-Le s te Dili 51 51 0 0.0 2 3.9 100.0

3857 3334 1591 47.7 305 17.5 86.9

Source: Reported by SEAR Measles Laboratory Netw ork NR=No Report

Indone s ia

Indone s ia Total

Thailand

Thailand Total

TOTAL

Me as le s +ve Rube lla +ve

India

Re s ults

% Me as le s Re s ults Re porte d w ithin 4 Days

India Total

Country Laboratorie s Num be r of Se rum

Sam ple s Re ce ive d Num be r Te s te d

Referensi

Dokumen terkait

REKAPITULASI REALISASI ANGGARAN BELANJA DAERAH MENURUT URUSAN PEMERINTAHAN DAERAH,. Anggaran

Metode yang digunakan dalam pengambilan keputusan untuk permasalahan dalam penelitian ini adalah metode ANP (Analitycal Network Process) yaitu salah satu metode yang

Kebun Raya Sriwijaya sebagai kawasan konservasi tumbuhan secara eksitu seluas 100 hektar, nantinya akan menjadi benteng terakhir biodiversitas tumbuhan obat dan lahan basah

Tingginya persentase pasien hipertensi yang menggunakan obat bahan alam sesuai dengan penelitian oleh Delima et al (2012) yang menunjukkan bahwa hipertensi berada di

Read this passage to answer questions number 5 to 9 Wholesaling is part of the marketing system which provides channels of distribution that are used to bring goods to market..

Oleh karena itu, kita harus belajar mengenal siapa diri kita, siapa orangtua kita, siapa teman kita dan masih banyak lagi yang harus kita ketahui.. Semua itu membutuhkan

PENGEMBANGAN INSTRUMEN PENILAIAN D IRI D AN PENILAIAN TEMAN SEJAWAT UNTUK MENILAI KINERJA SISWA SMK PAD A PRAKTIKUM PENGARUH KONSENTRASI TERHAD AP LAJU REAKSI Universitas

sebelumnya, maka perumusan masalah dalam penelitian ini adalah “apakah terdapat perbedaan antara kinerja keuangan Bank Pemerintah dengan kinerja keuangan Bank Asing